Milk-derived GM(3) and GD(3) differentially inhibit dendritic cell maturation and effector functionalities

Area of Science:

• Immunology
• Glycobiology
• Cell Biology

Background:

• Gangliosides are immune-modulating glycosphingolipids.
• GD(3) and GM(3) are abundant in human breast milk, with GD(3) decreasing and GM(3) increasing during lactation.
• The role of dietary gangliosides in infant immunity is not fully understood.

Purpose of the Study:

• To investigate the in vitro effects of gangliosides GD(3) and GM(3) on dendritic cell (DC) effector functions.
• To compare the inhibitory potential of GD(3) and GM(3) on DC maturation and immune cell activation.

Main Methods:

• Bone marrow-derived DCs were treated with GD(3) or GM(3) prior to lipopolysaccharide-induced maturation.
• Cytokine production (IL-6, IL-10, IL-12, TNF-alpha) was measured.
• DC alloreactivity in mixed leukocyte reactions (MLR) and surface marker expression (CD40, CD80, CD86, MHC class II) were assessed.

Main Results:

• GD(3) significantly reduced IL-6, IL-10, IL-12, and TNF-alpha production and decreased DC alloreactivity.
• GM(3) only inhibited IL-10 and IL-12 production and did not affect DC potency in MLR.
• Both gangliosides suppressed CD40, CD80, CD86, and MHC class II expression on DCs.
• GD(3) demonstrated a more potent inhibitory effect on DC functions compared to GM(3).

Conclusions:

• GD(3) exerts a stronger inhibitory effect on dendritic cell functions than GM(3).
• The immune-modulating impact of breast milk gangliosides may be more significant during early lactation when GD(3) levels are highest.